Cochrane · systematic review · CD008817

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Penninga, L, Penninga, EI, Møller, CH, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 6 · 85.7%Moderate 1 · 14.3%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Tacrolimus compared to cyclosporin for lung transplant recipients

Population: Lung transplant recipients
7 questions
OutcomeEffectEvidenceStatus / GRADE
Mortality Mortality at latest
Tacrolimus vs cyclosporin
RR 1.06 [0.75, 1.49]3 studies · 413 participantsLow
Downgraded: risk of bias
Acute rejection The number of patients who experienced at least one episode of rejection
Tacrolimus vs cyclosporin
RR 0.89 [0.77, 1.05]2 studies · 323 participantsLow
Downgraded: risk of bias
Bronchiolitis obliterans syndrome The number of patients diagnosed with the bronchiolitis obliterans syndrome
Tacrolimus vs cyclosporin
RR 0.46 [0.29, 0.74]3 studies · 413 participantsModerate
Downgraded: risk of bias
Infection The number of overall infections per 100 patient days
Tacrolimus vs cyclosporin
no estimate extracted1 study · 74 participantsLow
Downgraded: risk of bias
Treatment withdrawal the number of patients stopping the assigned drug intervention
Tacrolimus vs cyclosporin
RR 0.27 [0.16, 0.46]3 studies · 413 participantsLow
Downgraded: risk of bias
Arterial hypertension
Tacrolimus vs cyclosporin
RR 0.67 [0.5, 0.89]2 studies · 164 participantsLow
Downgraded: risk of bias
Diabetes mellitus
Tacrolimus vs cyclosporin
RR 4.24 [1.58, 11.4]2 studies · 164 participantsLow
Downgraded: risk of bias